Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

0.000p
   
  • Closing Price Chg:
    -2.00p
  • 52 Week High: 445.00p
  • 52 Week Low: 233.00p
  • Currency: UK Pounds
  • Shares Issued: 106.20m
  • Volume: 0
  • RiskGrade: 125
  • Beta: 0.02

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
78.72% above the market average78.72% above the market average78.72% above the market average78.72% above the market average78.72% above the market average
37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
17.66% above the market average17.66% above the market average17.66% above the market average17.66% above the market average17.66% above the market average
8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average8.33% below the sector average
Price Book Ratio
88.54% below the market average88.54% below the market average88.54% below the market average88.54% below the market average88.54% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
95.89% above the market average95.89% above the market average95.89% above the market average95.89% above the market average95.89% above the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Price Chg 3m
89.13% above the market average89.13% above the market average89.13% above the market average89.13% above the market average89.13% above the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
95.57% above the market average95.57% above the market average95.57% above the market average95.57% above the market average95.57% above the market average
95.12% above the sector average95.12% above the sector average95.12% above the sector average95.12% above the sector average95.12% above the sector average
Momentum 20
95.27% above the market average95.27% above the market average95.27% above the market average95.27% above the market average95.27% above the market average
90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average90.24% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
64.63% below the market average64.63% below the market average64.63% below the market average64.63% below the market average64.63% below the market average
26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average26.67% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
96.23% below the market average96.23% below the market average96.23% below the market average96.23% below the market average96.23% below the market average
95.45% below the sector average95.45% below the sector average95.45% below the sector average95.45% below the sector average95.45% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
27.57% above the market average27.57% above the market average27.57% above the market average27.57% above the market average27.57% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Operating Profit Loss
94.2% below the market average94.2% below the market average94.2% below the market average94.2% below the market average94.2% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
46.51% above the market average46.51% above the market average46.51% above the market average46.51% above the market average46.51% above the market average
60.98% above the sector average60.98% above the sector average60.98% above the sector average60.98% above the sector average60.98% above the sector average
Cash
57.40% above the market average57.40% above the market average57.40% above the market average57.40% above the market average57.40% above the market average
72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average72.09% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
41.85% below the market average41.85% below the market average41.85% below the market average41.85% below the market average41.85% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
43.79% below the market average43.79% below the market average43.79% below the market average43.79% below the market average43.79% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Brokers Percent Neutral
25.99% above the market average25.99% above the market average25.99% above the market average25.99% above the market average25.99% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 462.00p
Closing Price Change -2.00p
% Change 0.00 %
52 Week High 445.00p
52 Week Low 233.00p
Volume 0
Shares Issued 106.20m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.86% below the market average33.86% below the market average33.86% below the market average33.86% below the market average33.86% below the market average
16.28% above the sector average16.28% above the sector average16.28% above the sector average16.28% above the sector average16.28% above the sector average
Price Trend
60.23% above the market average60.23% above the market average60.23% above the market average60.23% above the market average60.23% above the market average
82.22% above the sector average82.22% above the sector average82.22% above the sector average82.22% above the sector average82.22% above the sector average
Income Not Available
Growth
4.33% above the market average4.33% above the market average4.33% above the market average4.33% above the market average4.33% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page